492 related articles for article (PubMed ID: 19624844)
1. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of autoantibody production in pristane-induced murine lupus.
Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
[TBL] [Abstract][Full Text] [Related]
3. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Chauhan SK; Singh VV; Rai R; Rai M; Rai G
J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
[TBL] [Abstract][Full Text] [Related]
4. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
[TBL] [Abstract][Full Text] [Related]
5. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.
Thibault DL; Chu AD; Graham KL; Balboni I; Lee LY; Kohlmoos C; Landrigan A; Higgins JP; Tibshirani R; Utz PJ
J Clin Invest; 2008 Apr; 118(4):1417-26. PubMed ID: 18340381
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
7. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
8. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor signalling in B cells during systemic lupus erythematosus.
Fillatreau S; Manfroi B; Dörner T
Nat Rev Rheumatol; 2021 Feb; 17(2):98-108. PubMed ID: 33339987
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
Clynes R; Calvani N; Croker BP; Richards HB
Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
[TBL] [Abstract][Full Text] [Related]
11. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of TLR7 and TLR9 in murine SLE.
Santiago-Raber ML; Baudino L; Izui S
J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
14. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.
Christensen SR; Shlomchik MJ
Semin Immunol; 2007 Feb; 19(1):11-23. PubMed ID: 17276080
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
Xu Y; Lee PY; Li Y; Liu C; Zhuang H; Han S; Nacionales DC; Weinstein J; Mathews CE; Moldawer LL; Li SW; Satoh M; Yang LJ; Reeves WH
J Immunol; 2012 Apr; 188(8):4113-21. PubMed ID: 22422888
[TBL] [Abstract][Full Text] [Related]
17. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.
Lee PY; Kumagai Y; Li Y; Takeuchi O; Yoshida H; Weinstein J; Kellner ES; Nacionales D; Barker T; Kelly-Scumpia K; van Rooijen N; Kumar H; Kawai T; Satoh M; Akira S; Reeves WH
J Exp Med; 2008 Dec; 205(13):2995-3006. PubMed ID: 19047436
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells.
Moody KL; Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
Methods Mol Biol; 2016; 1390():249-72. PubMed ID: 26803634
[TBL] [Abstract][Full Text] [Related]
19. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the role of nucleic acid antigens in murine models of systemic lupus erythematosus.
Watkins AA; Bonegio RG; Rifkin IR
Methods Mol Biol; 2014; 1169():143-58. PubMed ID: 24957237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]